[Breaking] HB Solution to Supply KRW 24.7 Billion Worth of Equipment to Chinese Display Company... Order Amounts to 39% of 2025 Revenue
HB Solution announced in a regulatory filing on the 7th that it has signed an equipment supply contract with Guangzhou China Star Optoelectronics Printing Displ
![[Breaking] HB Solution to Supply KRW 24.7 Billion Worth of Equipment to Chinese Display Company... Order Amounts to 39% of 2025 Revenue](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581911/a630da1c47d6049c/variants/hero.webp)
HB Solution announced in a regulatory filing on the 7th that it has signed an equipment supply contract with Guangzhou China Star Optoelectronics Printing Display Technology Co., Ltd., a Chinese display panel manufacturer.
- ■ Contract Overview
- Contract Amount: KRW 24,684,957,000 (USD 16,115,000)
- Percentage of Revenue: 39.28% of the 2025 consolidated revenue of KRW 62,848,643,582
- Exchange Rate Applied: Initial quoted exchange rate as of July 7, 2026 (1 USD = KRW 1,531.80)
- Contract Type: Unconditional firm contract (exclusive of VAT)
- Supply Region: China
- Contract Period: July 7, 2026 – March 4, 2027 (the end date may be changed by mutual agreement between the two parties)
- Order Date: July 7, 2026 (based on receipt of purchase order)
■ Payment Terms For the main equipment, payment will be divided as follows: 70% by Letter of Credit (L/C) after FOB, 20% by Telegraphic Transfer (T/T) after inspection, and 10% by T/T one year after inspection. Service fees will be paid 100% by T/T upon completion of inspection. There is no advance payment.
■ Counterparty The contracting counterparty is a company that manufactures and sells display panels.
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] KOSPI Plunges 8%, Triggering Level 1 Circuit Breaker... Trading Halted for 20 Minutes](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581295/f96ea0d6ae6103cc/variants/hero.webp)
![[Upcoming IPO] Ingenia Therapeutics Subscription Open July 30–31… LCIDEC Bispecific Antibody Platform and Vascular Disease New Drug in Focus](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/582901/0862e907e2395e27/variants/hero.webp)
![[Breaking] Jusung Engineering Triggers VI Twice During Session... Turns Lower to 170,000-Won Range After Early Surge](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581031/0c2a8f5a6d5bef88/variants/hero.webp)
